21. Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma. (November 2017) Authors: Hamid, Omid; Puzanov, Igor; Dummer, Reinhard; Schachter, Jacob; Daud, Adil; Schadendorf, Dirk; Blank, Christian; Cranmer, Lee D.; Robert, Caroline; Pavlick, Anna C.; Gonzalez, Rene; Hodi, F. Stephen; Ascierto, Paolo A.; Salama, April K.S.; Margolin, Kim A.; Gangadhar, Tara C.; Wei, Ziwen; Ebbingh... Journal: European journal of cancer Issue: Volume 86(2017) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma. (November 2016) Authors: Schadendorf, Dirk; Dummer, Reinhard; Hauschild, Axel; Robert, Caroline; Hamid, Omid; Daud, Adil; van den Eertwegh, Alfons; Cranmer, Lee; O'Day, Steven; Puzanov, Igor; Schachter, Jacob; Blank, Christian; Salama, April; Loquai, Carmen; Mehnert, Janice M.; Hille, Darcy; Ebbinghaus, Scot; Kang, S. Pe... Journal: European journal of cancer Issue: Volume 67(2016) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Increased FDG avidity in lymphoid tissue associated with response to combined immune checkpoint blockade. Issue 1 (December 2016) Authors: Tsai, Katy; Pampaloni, Miguel; Hope, Charity; Algazi, Alain; Ljung, Britt-Marie; Pincus, Laura; Daud, Adil Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Indirect treatment comparison of dabrafenib plus trametinib versus vemurafenib plus cobimetinib in previously untreated metastatic melanoma patients. Issue 1 (December 2017) Authors: Daud, Adil; Gill, Japinder; Kamra, Sheily; Chen, Lei; Ahuja, Amit Journal: Journal of hematology & oncology Issue: Volume 10:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Long-term outcomes in patients with advanced melanoma who had initial stable disease with pembrolizumab in KEYNOTE-001 and KEYNOTE-006. (November 2021) Authors: Hamid, Omid; Robert, Caroline; Daud, Adil; Carlino, Matteo S.; Mitchell, Tara C.; Hersey, Peter; Schachter, Jacob; Long, Georgina V.; Hodi, F. Stephen; Wolchok, Jedd D.; Arance, Ana; Grob, Jean Jacques; Joshua, Anthony M.; Weber, Jeffrey S.; Mortier, Laurent; Jensen, Erin; Diede, Scott J.; Moreno... Journal: European journal of cancer Issue: Volume 157(2021) Page Start: 391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Management of Treatment‐Related Adverse Events with Agents Targeting the MAPK Pathway in Patients with Metastatic Melanoma. (18th May 2017) Authors: Daud, Adil; Tsai, Katy Journal: Oncologist Issue: Volume 22:Number 7(2017) Page Start: 823 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Management of Treatment‐Related Adverse Events with Agents Targeting the MAPK Pathway in Patients with Metastatic Melanoma. (July 2017) Authors: Daud, Adil; Tsai, Katy Journal: Oncologist Issue: Volume 22:Number 7(2017) Page Start: 823 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Melanoma risk during immunomodulating treatment. Issue 6 (22nd August 2022) Authors: Zheng, Yixuan James; Ho, Wilson; Sanlorenzo, Martina; Vujic, Igor; Daud, Adil; Algazi, Alain; Rappersberger, Klemens; Ortiz-Urda, Susana Journal: Melanoma research Issue: Volume 32:Issue 6(2022) Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Melanoma treatment with intratumoral electroporation of tavokinogene telseplasmid (pIL-12, tavokinogene telseplasmid). (December 2017) Authors: Canton, David A; Shirley, Shawna; Wright, Jocelyn; Connolly, Richard; Burkart, Christoph; Mukhopadhyay, Anandaroop; Twitty, Chris; Qattan, Kristen E; Campbell, Jean S; Le, Mai H; Pierce, Robert H; Gargosky, Sharron; Daud, Adil; Algazi, Alain Journal: Immunotherapy Issue: Volume 9:Number 16(2017) Page Start: 1309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium. Issue 7 (July 2019) Authors: Andrews, Miles C; Berry, Donald A; Block, Matthew S; Boland, Genevieve M; Bollin, Kathryn B; Carlino, Matteo S; Carvajal, Richard D; Cohen, Jonathan; Davar, Diwakar; Delman, Keith A; Dummer, Reinhard; Farwell, Michael D; Fisher, David E; Fusi, Alberto; Glitza, Isabella C; de Gruijl, Tanja D; Gyor... Journal: Lancet oncology Issue: Volume 20:Issue 7(2019) Page Start: e378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗